{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:07:26Z","timestamp":1744178846380},"reference-count":69,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.eimc.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T02:40:44Z","timestamp":1366166444000},"page":"523-528","source":"Crossref","is-referenced-by-count":4,"title":["Does the current treatment of invasive fungal infection need to be reviewed?"],"prefix":"10.1016","volume":"32","author":[{"given":"Almudena","family":"Mart\u00edn-Pe\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Aguilar-Guisado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Miguel","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2013.02.008_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0010","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0015","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0020","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.eimc.2013.02.008_bib0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","article-title":"Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study\u2014Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne","volume":"45","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients","volume":"116","author":"Martino","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0609.2008.01096.x","article-title":"Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?","volume":"81","author":"Caira","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006\u20132008)","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.eimc.2013.02.008_bib0060","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0075","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.eimc.2013.02.008_bib0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0213-005X(12)70087-3","article-title":"Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients","volume":"30","author":"Berdaguer","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.02.008_bib0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkp251","article-title":"Incidence of candidaemia and relationship with fluconazole use in an intensive care unit","volume":"64","author":"Bassetti","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.02.008_bib0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/427759","article-title":"Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia","volume":"40","author":"Oren","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-5-1","article-title":"Hospital use of systemic antifungal drugs","volume":"5","author":"De With","year":"2005","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0100","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1517\/14656566.6.15.2617","article-title":"Pharmacoeconomics of antifungal pharmacotherapy\u2014challenges and future directions","volume":"6","author":"Johnson","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eimc.2013.02.008_bib0105","unstructured":"Red Espa\u00f1ola de Investigaci\u00f3n en Patolog\u00eda Infecciosa [Spanish Network for Research in Infectious Pathology]. Consumo de Antimicrobianos [Internet] [cited January 8, 2013]. Available from: http:\/\/www.reipi.org\/index.php\/es\/noticias-no-borrar\/122-consumo-de-antimicrobianos."},{"key":"10.1016\/j.eimc.2013.02.008_bib0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2146\/ajhp100423","article-title":"Antifungal use in hospitalized adults in U.S. academic health centers","volume":"68","author":"Pakyz","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.eimc.2013.02.008_bib0115","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.02.008_bib0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1439-0507.2010.01881.x","article-title":"Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies","volume":"54","author":"Hoenigl","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.eimc.2013.02.008_bib0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eimc.2010.12.003","article-title":"Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain)","volume":"29","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.02.008_bib0130","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.02.008_bib0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.eimc.2012.02.006","article-title":"Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006\u20132010","volume":"30","author":"Olaechea-Astigarraga","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.02.008_bib0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/664909","article-title":"Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program","volume":"33","author":"Standiford","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.eimc.2011.01.008","article-title":"Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update","volume":"29","author":"Aguado","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.02.008_bib0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.eimc.2011.01.010","article-title":"Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update","volume":"29","author":"Fort\u00fan","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.02.008_bib0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20142009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.eimc.2013.02.008_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0175","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group","volume":"86","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/514672","article-title":"Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia","volume":"27","author":"White","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer","volume":"108","author":"Winston","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0190","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph\/ABLC Collaborative Study Group","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0200","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0213-005X(05)75041-2","article-title":"Empirical antifungal therapy in selected patients with persistent fever and neutropenia","volume":"23","author":"Cisneros","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.02.008_bib0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0609.2004.00273.x","article-title":"Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients","volume":"73","author":"Jantunen","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0215","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","article-title":"Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1\u21923)-beta-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0220","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.2004.05140.x","article-title":"Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients","volume":"126","author":"Maertens","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0225","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jac\/dkm217","article-title":"Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients","volume":"60","author":"Oshima","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.02.008_bib0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/bmt.2008.427","article-title":"An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality","volume":"44","author":"Dignan","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.eimc.2013.02.008_bib0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2009.125","article-title":"Empirical antifungal therapy in selected patients with persistent febrile neutropenia","volume":"45","author":"Aguilar-Guisado","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.eimc.2013.02.008_bib0240","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2009.21.8032","article-title":"Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study","volume":"28","author":"Girmenia","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0245","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0250","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2011.049999","article-title":"Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach","volume":"97","author":"Aguilar-Guisado","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.eimc.2013.02.008_bib0255","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2013.02.008_bib0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/14737159.8.3.315","article-title":"Contribution of serum biomarkers to the diagnosis of invasive candidiasis","volume":"8","author":"La\u00edn","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.eimc.2013.02.008_bib0275","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia","volume":"14","author":"Mikulska","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.eimc.2013.02.008_bib0280","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/JCM.34.9.2175-2179.1996","article-title":"Diagnosis of disseminated candidiasis by measurement of urine d-arabinitol\/l-arabinitol ratio","volume":"34","author":"Lehtonen","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2013.02.008_bib0285","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.eimc.2013.02.008_bib0290","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0295","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.eimc.2013.02.008_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03615.x","article-title":"European expert opinion on the management of invasive candidiasis in adults","volume":"17","author":"Kullberg","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2013.02.008_bib0310","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.02.008_bib0315","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0320","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0325","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cis524","article-title":"Selection bias in Andes et al.","volume":"55","author":"Cisneros","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0330","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.02.008_bib0335","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.02.008_bib0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijid.2011.10.004","article-title":"The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review","volume":"16","author":"Garbati","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"Suppl. 3s","key":"10.1016\/j.eimc.2013.02.008_bib0345","first-page":"713","article-title":"A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis","volume":"18","author":"Marr","year":"2012","journal-title":"Clin Microbiol Infect"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X13000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X13000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T13:04:56Z","timestamp":1595682296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X13000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0213005X13000530"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2013.02.008","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}